These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Mechanism of cleft palate in C57BL/6N mice induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin].
    Author: Wu Y, Zhang YW, Yue HD, Gao SH, He ZD, Chen Y, Yu ZL, Liu XZ.
    Journal: Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Apr 09; 57(4):397-402. PubMed ID: 35368166.
    Abstract:
    Objective: To explore the molecular mechanism of cleft palate in mice induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). Methods: The pregnant mice were randomly divided into TCDD-treated group (n=42) and control group (n=42). TCDD-treated group was given by gavage a single dose of TCDD (64 μg/kg) at 8: 00 AM on gestation day 10 (GD10) and the control group was given by gavage the isopyknic corn oil. At GD13-GD15, the fetal mice palate development was observed by HE staining. The mouse embryonic palatal mesenchymal cell proliferation was detected by 5-bromo-2-deoxyuridine (BrdU) immunofluorescence. The localization and expression of maternally expressed gene3 (MEG3) in mouse embryonic palatal mesenchymal cells was detected by situ hybridization and real-time PCR (RT-PCR). The key protein expressions of transforming growth factor-β (TGF-β)/Smad signaling pathway in mouse embryonic palatal mesenchyme were analyzed by Western blotting. The interaction of MEG3 and TGF-β receptor Ⅰ (TGF-βRⅠ) was examined by RNA binding protein immunoprecipitation (RIP). Results: At GD13 and GD14, compared with the control group, the ratio of BrdU-positive cells in the palatal mesenchyme of TCDD-treated fetuses decreased significantly (GD13, t=6.66, P=0.003; GD14, t=6.56, P=0.003). However, at GD15, the ratio of BrdU-positive cells was significantly increased (t=-5.98, P=0.004). MEG3 was mainly expressed in the nuclei of fetal mouse palatal mesenchymal cells, and the expression of MEG3 in TCDD group was significantly increased at GD13, GD14 and GD15(GD13, t=39.28, P=0.012; GD14, t=18.75, P=0.042; GD15, t=28.36, P=0.045). At GD14, TCDD decreased the levels of p-Smad2 and Smad4 in embryonic palate mesenchymal cells (p-Smad2, t=9.48, P=0.001;Smad4, t=63.10, P=0.001), whereas the expression of Smad7 was significantly increased at GD14 (t=30.77, P<0.001). The results of the RIP experiment showed that the amount of TGF-βRⅠ-bound MEG3 in mouse embryonic palatal mesenchymal cells in the TCDD group (23.940±1.301) was higher than that in the control group (8.537±1.523)(t=24.55, P<0.001). Conclusions: MEG3 is involved in the suppression of mouse embryonic palatal mesenchymal cell proliferation, functioning at least in part via interacting with the TGF-βRⅠ protein and thereby suppressing Smad signaling in the context of TCDD induced cleft palate. 目的: 探索2,3,7,8-四氯二苯并二(牙合)英(2,3,7,8-tetrachlorodibenzo-p-dioxin,TCDD)诱发小鼠腭裂的作用及机制。 方法: 将84只孕鼠根据体质量按随机数字表随机分为TCDD组和对照组(每组42只),在孕期第10天(gestation day 10,GD10)上午8时分别给予64 μg/kg TCDD和等量玉米油灌胃。HE染色观察GD13~GD15胎鼠腭发育的形态学变化,5-溴脱氧尿嘧啶核苷(5-bromo-2-deoxyuridine,BrdU)免疫荧光观察TCDD对GD13~GD15胎鼠腭突间充质细胞增殖的影响,原位杂交和实时定量PCR(real-time PCR,RT-PCR)检测母系印记基因3(maternally expressed gene3,MEG3)在胎鼠腭突间充质细胞中的定位和表达,蛋白质印迹法检测胎鼠腭突间充质细胞内Smad2、磷酸化Smad2(phospho-Smad2,p-Smad2)、Smad4、Smad7的蛋白表达,RNA 结合蛋白免疫沉淀实验(RNA binding protein immunoprecipitation,RIP)验证MEG3与转化生长因子β受体Ⅰ(transforming growth factor-β receptor Ⅰ,TGF-βRⅠ)的相互作用。 结果: 与对照组相比,TCDD组GD13(t=6.66,P=0.003)和GD14(t=6.56,P=0.003)胎鼠腭突间充质细胞中BrdU阳性细胞率显著减少,但在GD15时BrdU阳性细胞率显著增加(t=-5.98,P=0.004)。原位杂交显示MEG3主要表达于间充质细胞的细胞核。RT-PCR结果显示,TCDD组腭突间充质细胞内的MEG3相对表达量显著高于对照组(GD13:t=39.28,P=0.012;GD14:t=18.75,P=0.042;GD15:t=28.36,P=0.045)。在GD14,TCDD组胎鼠腭突间充质细胞内p-Smad2、Smad4蛋白表达均显著低于对照组(p-Smad2:t=9.48,P=0.001;Smad4:t=63.10,P=0.001),Smad7蛋白表达量显著高于对照组(t=30.77,P<0.001)。RIP实验结果显示,TCDD组GD14胎鼠腭突间充质细胞中TGF-βRⅠ结合MEG3的表达量(23.940±1.301)显著高于对照组(8.537±1.523)(t=24.55,P<0.001)。 结论: TCDD可能通过促进MEG3与TGF-βRⅠ的靶向结合影响TGF-β/Smad信号途径的激活,从而抑制腭突间充质细胞的增殖,由此导致腭裂的发生。.
    [Abstract] [Full Text] [Related] [New Search]